Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [<sup>153</sup>Sm]Sm-DOTA-TATE
Samarium-153 is a promising theranostic radionuclide, but low molar activities (A<sub>m</sub>) resulting from its current production route render it unsuitable for targeted radionuclide therapy (TRNT). Recent efforts combining neutron activation of <sup>152</sup>Sm in the SCK CEN BR2 reactor with ma...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2022-11-01
|
| Reeks: | Pharmaceutics |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/1999-4923/14/12/2566 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
